Motif Neurotech

Private

Houston, TexasHealthcare & Life Scienceshttps://motifneuro.tech/

Last Round

Grant

Jan 20, 2025

Total Funding Raised

$24.75M

Company Overview

Motif Neurotech is a biotechnology company that develops minimally invasive bioelectronic systems for treating treatment-resistant depression through innovative wireless power and data technologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIneurostimulationimplantable medical devicetreatment-resistant depressionneurotechbrain implantminimally invasive surgerymental health therapyneural signal processingbioelectronicsneuromodulationclinical trialsmedical hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Motif Neurotech Comparables

Compare Motif Neurotech with similar companies based on industry and business-model similarity.

Motif Neurotech comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Motif Neurotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 20, 2025
Series A	Jan 24, 2024
Accelerator	Feb 27, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Jacob Robinson

Co-Founder And CEO

Founding Team

Steven Goetz

Chief Technology Officer

Executive Team

Nick Halper

Chief Operating Officer

Executive Team

Motif Neurotech Investors

Notable investors and investment history

Motif Neurotech investors
Investor	Rounds
Dolby Family Ventures	Series A
Arboretum Ventures	Series A
re.Mind Capital	Series A
Capital Factory	Series A
Advanced Research and Invention Agency	Grant
Texas Medical Center	Series A
Empath Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 14, 2025
Developing a neurostimulator system for severe depression treatment.
Jan 20, 2025
Secured $6M in grant funding.

View all signals

Motif Neurotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Motif Neurotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Motif Neurotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas

Employee Range32

Year Founded2022

Last FundingJan 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.